CME Programs

Each CME-accredited program can be used to gain a maximum of one (1.0) AMA PRA Category 1 CreditsTM through completion of a questionnaire concerning the program content.

Program 1: A Transdermal Methylphenidate Delivery System

September 28th 2006
Activity expires September 27th 2007
Featuring Dr Frank Lopez and Dr Sharon Wigal

In the first issue, Dr Findling invites Drs Frank Lopez and Sharon Wigal to discuss the newly-launched methylphenidate transdermal delivery system. Dr Wigal has authored a recent study investigating the system, and Dr Lopez has also been involved in its pre-approval testing. Together with Dr Findling they debate the benefits and drawbacks of the transdermal delivery system and provide us with the fruits of their extensive knowledge on the subject.

 

 

Program 2: Adult ADHD

January 26th 2007
Activity expires January 25th 2008
Featuring Dr Craig Surman and Dr Richard Weisler

In this second CME program, Dr Findling discusses the particular challenges of ADHD in adults with Dr Craig Surman and Dr Richard Weisler. The talk encompasses the clinical presentation of these patients, along with comorbidities, pre-prescribing checks, and behavioral and pharmacological management of the condition.

Dr. Surman coordinates the Adult ADHD Research Program at Massachusetts General Hospital. Dr. Weisler has authored journal articles and book chapters on ADHD, and has been actively involved in the development of many approved and investigational treatments for ADHD.

 

 

Program 3: The Preschool ADHD Treatment Study

May 4th 2007
Activity expires May 3rd 2008
Featuring Dr Jaswinder Ghuman and Dr Scott Kollins

This third CME program considers the Preschool ADHD Treatment Study, whose results were published at the end of 2006. Dr Jaswinder Ghuman of the University of Arizona and Dr Scott Kollins of Duke University Medical Center were study investigators and they tell Dr Findling how the study was designed, what it found, and ultimately what the implications are for prescribers and for families with children aged 3–6 years suffering from ADHD.

 

 

Program 4: Long-term Treatment Issues in ADHD

August 31st 2007
Activity expires August 30th 2008
Featuring Dr Larry Culpepper and Dr Raul Silva

The fourth CME discussion focuses on the benefits and drawbacks of long-term pharmacological treatment of ADHD. Dr Larry Culpepper of Boston University School of Medicine and Dr Raul Silva of New York University School of Medicine and Rockland Children’s Psychiatric Center talk about the chronic nature of ADHD and the need for long-term treatment with Dr Findling, and provide advice for informing patients about the frequency and nature of adverse effects associated with treatment.